An Atypical Pneumonia Case of Quinolone-Refractory Chlamydia Pneumoniae Successfully Treated With Omadacycline
Jiahuan Tong1, Linshui Zhou1, Yan Chen2
1Department of Respiratory Diseases, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, People's Republic of China.
Abstract:
Atypical pneumonia caused by Chlamydia pneumoniae often presents diagnostic challenges due to its nonspecific symptoms and slow progression. While most cases are mild and self-limiting, severe infections in immunocompetent adults are rare. This report describes a 32-year-old Chinese female with progressive pneumonia unresponsive to empirical quinolone therapy. Bronchoalveolar lavage (BAL) and next-generation sequencing (NGS) identified C. pneumoniae as the causative pathogen. The patient showed significant clinical improvement following treatment with omadacycline, a novel tetracycline-class antibiotic. This case highlights the importance of bronchoscopic evaluation, BAL cytology, and NGS in diagnosing atypical pneumonia. It also underscores omadacycline's potential in treating quinolone-refractory C. pneumoniae pneumonia.
Insights
Severe Chlamydia pneumoniae pneumonia in an immunocompetent adult, diagnosed using next-generation sequencing, responded well to omadacycline, a novel antibiotic, after failing quinolone treatment.
Area of Science:
- Infectious Diseases
- Microbiology
- Pulmonology
Background:
- Atypical pneumonia caused by Chlamydia pneumoniae presents diagnostic challenges due to nonspecific symptoms.
- Severe C. pneumoniae infections in immunocompetent adults are rare but can be difficult to treat.
Observation:
- A 32-year-old Chinese female presented with progressive pneumonia unresponsive to empirical quinolone therapy.
- Diagnostic workup included bronchoscopic evaluation and bronchoalveolar lavage (BAL).
Findings:
- Next-generation sequencing (NGS) of BAL fluid identified C. pneumoniae as the causative agent.
- The patient experienced significant clinical improvement after treatment with omadacycline, a novel tetracycline-class antibiotic.
Implications:
- This case highlights the utility of bronchoscopy, BAL, and NGS in diagnosing challenging atypical pneumonia cases.
- Omadacycline demonstrates potential efficacy in treating quinolone-refractory C. pneumoniae pneumonia.
More Related Videos
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...